The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Global spread of carbapenem-resistant Enterobacteriaceae: Epidemiological features, resistance mechanisms, detection and therapy
Open accessAbstract
Bacterial drug resistance has become a global public health threat, among which the infection of carbapenem-resistant Enterobacterales (CRE) is one of the top noticeable issues in the global anti-infection area due to limited therapy options. In recent years, the prevalence of CRE transmission around the world has increased, and the transmission of COVID-19 has intensified the situation to a certain extent. CRE resistance can be induced by carbapenemase, porin, efflux pump, penicillin-binding protein alteration, and biofilm production. Deletion, mutation, insertion, and post-transcriptional modification of corresponding coding genes may affect the sensitivity of Enterobacterales bacteria to carbapenems. Clinical and laboratory methods to detect CRE and explore its resistance mechanisms are being developed. Due to the limited options of antibiotics, the clinical treatment of CRE infection also faces severe challenges. The clinical therapies of CRE include single or combined use of antibiotics, and some new antibiotics and treatment methods are also being developed. Hence, this review summarizes the epidemiology, resistance mechanisms, screening and clinical treatments of CRE infection, to provide references for clinical prevention, control and treatment of CRE infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Self-citationTacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Carbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
Kortright, K. E., Chan, B. K., Koff, J. L., & Turner, P. E. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.014 · Cited by 1,212
OXA-48-like carbapenemases: the phantom menace
Poirel, L., Potron, A., & Nordmann, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks121 · Cited by 924
Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria
Nordmann, P., & Poirel, L. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz824 · Cited by 721
Beta-lactamase database (BLDB) – structure and function
Naas, T., Oueslati, S., Bonnin, R. A., Dabos, M. L., Zavala, A., Dortet, L., Retailleau, P., & Iorga, B. I. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1344235 · Cited by 701
Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
Doi, Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz830 · Cited by 652
The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae
Wang, G., Zhao, G., Chao, X., Xie, L., & Wang, H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176278 · Cited by 591
van der Zwaluw, K., de Haan, A., Pluister, G. N., Bootsma, H. J., de Neeling, A. J., & Schouls, L. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0123690 · Cited by 486
The Global Ascendency of OXA-48-Type Carbapenemases
Pitout, J. D. D., Peirano, G., Kock, M. M., Strydom, K.-A., & Matsumura, Y. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-19 · Cited by 478
Zhang, Y., Wang, Q., Yin, Y., Chen, H., Jin, L., Gu, B., Xie, L., Yang, C., Ma, X., Li, H., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01882-17 · Cited by 450
Self-citationMotsch, J., Murta de Oliveira, C., Stus, V., Köksal, I., Lyulko, O., Boucher, H. W., Kaye, K. S., File, T. M., Brown, M. L., Khan, I., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz530 · Cited by 422
Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU
Sharifipour, E., Shams, S., Esmkhani, M., Khodadadi, J., Fotouhi-Ardakani, R., Koohpaei, A., Doosti, Z., & EJ Golzari, S. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05374-z · Cited by 417
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab295 · Cited by 390
Han, R., Shi, Q., Wu, S., Yin, D., Peng, M., Dong, D., Zheng, Y., Guo, Y., Zhang, R., Hu, F., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00314 · Cited by 386
Wang, M., Earley, M., Chen, L., Hanson, B. M., Yu, Y., Liu, Z., Salcedo, S., Cober, E., Li, L., Kanj, S. S., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00399-6 · Cited by 363
Self-citationWang, Q., Wang, X., Wang, J., Ouyang, P., Jin, C., Wang, R., Zhang, Y., Jin, L., Chen, H., Wang, Z., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy660 · Cited by 349
Self-citationCarbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia
Hsu, L.-Y., Apisarnthanarak, A., Khan, E., Suwantarat, N., Ghafur, A., & Tambyah, P. A. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-16 · Cited by 339
van Duin, D., Arias, C. A., Komarow, L., Chen, L., Hanson, B. M., Weston, G., Cober, E., Garner, O. B., Jacob, J. T., Satlin, M. J., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30755-8 · Cited by 337
Sawa, T., Kooguchi, K., & Moriyama, K. (2020) · Journal of Intensive Care · doi:10.1186/s40560-020-0429-6 · Cited by 296
Phenotypic Detection of Carbapenemase-Producing Organisms from Clinical Isolates
Tamma, P. D., & Simner, P. J. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01140-18 · Cited by 293
van Loon, K., Voor in ‘t holt, A. F., & Vos, M. C. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01730-17 · Cited by 269
Diene, S. M., & Rolain, J.-M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12655 · Cited by 231
Falcone, M., Bassetti, M., Tiseo, G., Giordano, C., Nencini, E., Russo, A., Graziano, E., Tagliaferri, E., Leonildi, A., Barnini, S., et al. (2020) · Critical Care · doi:10.1186/s13054-020-2742-9 · Cited by 225
Mediavilla, J. R., Patrawalla, A., Chen, L., Chavda, K. D., Mathema, B., Vinnard, C., Dever, L. L., & Kreiswirth, B. N. (2016) · mBio · doi:10.1128/mbio.01191-16 · Cited by 218
Tiri, B., Sensi, E., Marsiliani, V., Cantarini, M., Priante, G., Vernelli, C., Martella, L. A., Costantini, M., Mariottini, A., Andreani, P., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9092744 · Cited by 215
Tompkins, K., & van Duin, D. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-021-04296-1 · Cited by 190
OmpK36-mediated Carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo
Wong, J. L. C., Romano, M., Kerry, L. E., Kwong, H.-S., Low, W.-W., Brett, S. J., Clements, A., Beis, K., & Frankel, G. (2019) · Nature Communications · doi:10.1038/s41467-019-11756-y · Cited by 185
Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae
McKinnell, J. A., Dwyer, J. P., Talbot, G. H., Connolly, L. E., Friedland, I., Smith, A., Jubb, A. M., Serio, A. W., Krause, K. M., & Daikos, G. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1807634 · Cited by 180
De Angelis, G., Del Giacomo, P., Posteraro, B., Sanguinetti, M., & Tumbarello, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145090 · Cited by 176
Hamzaoui, Z., Ocampo-Sosa, A. A., Martinez, M. F., Landolsi, S., Ferjani, S., Maamar, E., Saïdani, M., Slim, A. F., Martı́nez-Martı́nez, L., & Boubaker, I. B.-B. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.03.020 · Cited by 153
Carbapenem-resistant Enterobacteriaceae: An emerging bacterial threat
Lutgring, J. D. (2019) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2019.04.011 · Cited by 152
RND Efflux Pumps in Gram-Negative Bacteria; Regulation, Structure and Role in Antibiotic Resistance
Colclough, A., Alav, I., Whittle, E. E., Pugh, H. L., Darby, E. M., Legood, S., McNeil, H. E., & Blair, J. M. A. (2020) · Future Microbiology · doi:10.2217/fmb-2019-0235 · Cited by 152
Falcone, M., Tiseo, G., Giordano, C., Leonildi, A., Menichini, M., Vecchione, A., Pistello, M., Guarracino, F., Ghiadoni, L., Forfori, F., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa530 · Cited by 151
Sekyere, J. O., & Amoako, D. G. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00228 · Cited by 131
Kotb, S., Lyman, M., Ismail, G., Fattah, M. A. E., Girgis, S. A., Etman, A., Hafez, S., El-Kholy, J., Zaki, M. E. S., Rashed, H. G., et al. (2020) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0639-7 · Cited by 123
Lai, C. K. C., Ng, R. W. Y., Leung, S. S. Y., Hui, M., & Ip, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114078 · Cited by 121
Veleba, M., Higgins, P. G., González, G., Seifert, H., & Schneiders, T. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00456-12 · Cited by 117
Zhou, N., Cheng, Z., Zhang, X., Lv, C., Guo, C., Liu, H., Dong, K., Zhang, Y., Liu, C., Chang, Y., et al. (2022) · Infectious Diseases of Poverty · doi:10.1186/s40249-022-01016-5 · Cited by 108
Self-citationMalchione, M. D., Torres, L. M., Hartley, D., Koch, M., & Goodman, J. L. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.07.019 · Cited by 106
Adler, M., Anjum, M., Andersson, D. I., & Sandegren, L. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv475 · Cited by 99
Han, J., Goldstein, E. J. C., Wise, J. A., Bilker, W. B., Tolomeo, P., & Lautenbach, E. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw856 · Cited by 93
Whole genome sequencing reveals hidden transmission of carbapenemase-producing Enterobacterales
Marimuthu, K., Venkatachalam, I., Koh, V. J. W., Harbarth, S., Perencevich, E. N., Cherng, B. P. Z., Fong, R. K. C., Pada, S., Ooi, S. T., Smitasin, N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30637-5 · Cited by 92
Mmatli, M., Mbelle, N. M., Maningi, N. E., & Sekyere, J. O. (2020) · mSystems · doi:10.1128/msystems.00783-20 · Cited by 89
Yao, Y., Falgenhauer, L., Falgenhauer, J. C., Hauri, A. M., Heinmüller, P., Domann, E., Chakraborty, T., & Imirzalioglu, C. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.744431 · Cited by 86
Wang, Z., Cai, R., Wang, G., Guo, Z., Liu, X., Guan, Y., Ji, Y., Zhang, H., Xi, H., Zhao, R., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.674068 · Cited by 82
Carbapenem-Resistant Klebsiella pneumoniae Infections in ICU COVID-19 Patients—A Scoping Review
Mędrzycka-Dąbrowska, W. A., Lange, S., Zorena, K., Dąbrowski, S., Ozga, D., & Tomaszek, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10102067 · Cited by 78
Masi, M., Winterhalter, M., & Pagès, J. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-030-18768-2_4 · Cited by 77
Bar‐Yoseph, H., Carasso, S., Shklar, S., Korytny, A., Dar, R. E., Daoud, H., Nassar, R., Maharshak, N., Hussein, K., Geffen, Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa737 · Cited by 76
Sader, H. S., Carvalhaes, C. G., Arends, S. J. R., Castanheira, M., & Mendes, R. E. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa504 · Cited by 76
Using the best available data to estimate the cost of antimicrobial resistance: a systematic review
Wozniak, T. M., Barnsbee, L., Lee, X. J., & Pacella, R. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0472-z · Cited by 74
Mitgang, E. A., Hartley, D., Malchione, M. D., Koch, M., & Goodman, J. L. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.05.019 · Cited by 68
Carbapenem and Colistin Resistance in Enterobacter: Determinants and Clones
Zong, Z., Feng, Y., & McNally, A. (2021) · Trends in Microbiology · doi:10.1016/j.tim.2020.12.009 · Cited by 67
Huang, H., Dong, N., Shu, L., Lu, J., Sun, Q., Chan, E. W., Chen, S., & Zhang, R. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1717380 · Cited by 64
GERMS-SA, F., Perovic, O., Ismail, H., Quan, V., Bamford, C., Nana, T., Chibabhai, V., Bhola, P., Ramjathan, P., Swe-Han, K. S., et al. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03845-4 · Cited by 64
Fecal microbiota transplantation for Carbapenem-Resistant Enterobacteriaceae: A systematic review
Macareño-Castro, J., Solano-Salazar, A., Dong, L. T., Mohiuddin, M., & Espinoza, J. L. (2022) · Journal of Infection · doi:10.1016/j.jinf.2022.04.028 · Cited by 63
Philippe, N., Maigre, L., Santini, S., Pinet, E., Claverie, J., Davin‐Regli, A., Pagès, J., & Masi, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138828 · Cited by 61
Enhanced Klebsiella pneumoniae Carbapenemase Expression from a Novel Tn 4401 Deletion
Cheruvanky, A., Stoesser, N. E., Sheppard, A. E., Crook, D. W., Hoffman, P. S., Weddle, E., Carroll, J., Sifri, C. D., Chai, W., Barry, K., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00025-17 · Cited by 60
Nagaraj, G., Shamanna, V., Govindan, V., Rose, S., Sravani, D., Akshata, K. P., Shincy, M. R., Venkatesha, V., Abrudan, M. I., Argimón, S., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab767 · Cited by 60
Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016–2018
Paveenkittiporn, W., Lyman, M., Biedron, C., Chea, N., Bunthi, C., Kolwaite, A. R., & Janejai, N. (2021) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-021-00950-7 · Cited by 55
Peng, D., Li, X., Pin, L., Zhou, X., Luo, M., Su, K., Chen, S., Zhang, Z., He, Q., Qiu, J., et al. (2018) · Microbiological Research · doi:10.1016/j.micres.2018.08.010 · Cited by 54
Molecular epidemiology & therapeutic options of carbapenem-resistant Gram-negative bacteria
Garg, A., Garg, J., Kumar, S., Bhattacharya, A., Agarwal, S., & Upadhyay, G. C. (2019) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_36_18 · Cited by 53
Ranjitkar, S., Reck, F., Ke, X., Zhu, Q., McEnroe, G. A., López, S., & Dean, C. R. (2019) · mSphere · doi:10.1128/msphere.00074-19 · Cited by 46
Jiang, Y., Zhang, Y., Lu, J., Wang, Q., Cui, Y., Wang, Y., Quan, J., Zhao, D., Du, X., Liu, H., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30001-x · Cited by 46
Self-citationPaveenkittiporn, W., Kamjumphol, W., Ungcharoen, R., & Kerdsin, A. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.586368 · Cited by 43
Porin Deficiency in Carbapenem-Resistant Enterobacter aerogenes Strains
Hao, M., Ye, M., Shen, Z., Hu, F., Yang, Y., Wu, S., Xu, X., Zhu, S., Qin, X., & Wang, M. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0379 · Cited by 42
Ali, A., Gupta, D., Srivastava, G., Sharma, A. K., & Khan, A. U. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1475261 · Cited by 42
Su, K., Zhou, X., Luo, M., Xu, X., Pin, L., Li, X., Xue, J., Chen, S., Xu, W., Li, Y., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.06.036 · Cited by 42
Fang, R., Liu, H., Zhang, X., Dong, G., Li, J., Tian, X., Wu, Z., Zhou, J., Cao, J., & Zhou, T. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.104743 · Cited by 40
Carbapenem-Resistant Klebsiella pneumoniae Associated with COVID-19
Dumitru, I. M., Dumitrașcu, M., Vlad, N.-D., Cernat, R. C., Ilie-Serban, C., Hangan, A., Slujitoru, R., Gherghina, A., Mitroi-Maxim, C., Curtali, L., et al. (2021) · Antibiotics · doi:10.3390/antibiotics10050561 · Cited by 38
Weak biofilm formation among carbapenem-resistant Klebsiella pneumoniae
Cusumano, J. A., Caffrey, A. R., Daffinee, K. E., Luther, M. K., Lopes, V., & LaPlante, K. L. (2019) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2019.114877 · Cited by 37
Takeuchi, D., Kerdsin, A., Akeda, Y., Sugawara, Y., Sakamoto, N., Matsumoto, Y., Motooka, D., Ishihara, T., Nishi, I., Laolerd, W., et al. (2022) · Microbial Genomics · doi:10.1099/mgen.0.000797 · Cited by 37
Kim, J. S., Yu, J. K., Jeon, S. J., Park, S.-H., Han, S., Park, S. H., Jang, J. I., Jang, J. I., Shin, E., Kim, J., et al. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106418 · Cited by 36
Lin, T., Chen, Y., Kuo, J., Lai, Y., Wu, C.-C., Huang, C.-F., & Lin, C.-T. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02405 · Cited by 34
Sharma, D., Garg, A., Kumar, M., Rashid, F., & Khan, A. U. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02865 · Cited by 34
Abdelaziz, N. A. (2022) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-022-01061-7 · Cited by 33
Bao, J., Xie, L., Ma, Y., An, R., Gu, B., & Wang, C. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.778190 · Cited by 31
Genetic Factors Associated with Enhanced bla KPC Expression in Tn 3 /Tn 4401 Chimeras
Huang, J., Hu, X., Zhao, Y., Shi, Y., Ding, H., Xv, J., Ren, J., Wu, R., & Zhao, Z. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01836-19 · Cited by 25
Lee, J.-J., Yong, D., Suk, K. T., Kim, D. J., Woo, H., Lee, S. S., & Kim, B. S. (2021) · Microorganisms · doi:10.3390/microorganisms9020352 · Cited by 24
Tsilipounidaki, K., Athanasakopoulou, Z., Müller, E., Burgold-Voigt, S., Florou, Z., Braun, S. D., Monecke, S., Gatselis, N., Zachou, K., Stefos, A., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10010159 · Cited by 21
Pávez, M., Vieira, C. A., de Araujo, M. R., Cerda, Á., de Almeida, L. M., Lincopán, N., & Mamizuka, E. M. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.016 · Cited by 20
Alzayn, M., Dulyayangkul, P., Satapoomin, N., Heesom, K. J., & Avison, M. B. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01004-21 · Cited by 20
Wu, L.-T., Guo, M.-K., Ke, S.-C., Lin, Y., Pan, Y., Nguyen, H. T. V., & Chen, C. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0410 · Cited by 19
Huang, P.-H., Chen, W., Chou, S.-H., Wang, F., & Lin, Y.-T. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00381-22 · Cited by 19
Marí-Almirall, M., Ferrando, N., Fernández, M. J., Cosgaya, C., Viñes, J., Rubio-García, E., Cuscó, A., Muñoz, L., Pellicé, M., Vergara, A., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.781127 · Cited by 18
Probst, K., Nurjadi, D., Heeg, K. M., Frede, A.-M., Dalpke, A. H., & Boutin, S. (2021) · Antibiotics · doi:10.3390/antibiotics10060726 · Cited by 16
Jamal, A. J., Mataseje, L. F., Williams, V. S., Leis, J. A., Tijet, N., Zittermann, S. I., Melano, R. G., Mulvey, M. R., Katz, K. C., Allen, V. G., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00360-21 · Cited by 14
Genomic analysis of VIM-2-producing Enterobacter hormaechei subsp. steigerwaltii
Bonnin, R. A., Girlich, D., Jousset, A. B., Emeraud, C., Creton, E., Gauthier, L., Jové, T., Dortet, L., & Naas, T. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106285 · Cited by 13
Kalu, M. C., Tan, K. K., Algorri, M., Jorth, P. A., & Wong‐Beringer, A. (2022) · mSphere · doi:10.1128/msphere.00190-22 · Cited by 12
Hao, J., Zeng, Z., Xiao, X., Ding, Y., Deng, J., Wei, Y., & Liu, J. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s355010 · Cited by 10
Babiker, A., Bower, C. W., Lutgring, J. D., Petit, R. A., Howard-Anderson, J. R., Ansari, U. A., McAllister, G. A., Adamczyk, M., Breaker, E., Satola, S. W., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02522-21 · Cited by 10
Li, S., Jiang, X., Li, C., Ju, Y., Yue, L., Chen, F., Hu, L., Wang, J., Hu, X. Y., Tuohetaerbaike, B., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.973901 · Cited by 10
Self-citationChetri, S., -, K. S., Bhowmik, D., Chanda, D. D., Chakravarty, A., & Bhattacharjee, A. (2018) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_18_436 · Cited by 8
Zhou, Y., Zhao, Z., Zeng, L., Peng, J., Zhou, S., Min, L., Ke, J., & Liu, J. (2022) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001482 · Cited by 5
Metadata
- Authors
- Ma, J., Song, X., Li, M., Yu, Z., Cheng, W., Yu, Z., Zhang, W., Zhang, Y., Shen, A., Sun, H., & Li, L.
- Venue
- Microbiological Research
- Publisher
- Elsevier BV
- Published
- 2023-01
- Volume
- 266
- Pages
- 127249
- ISSN
- 0944-5013 (ISSN-L)
- OpenAlex
- W4308194807
- Cited by
- 308
- References
- 96
- FWCI
- 14.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.